Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302418 · ClinicalTrials.gov registry record
Collection and Testing of Respiratory Samples
A clinical trial, sponsored by QIAGEN Gaithersburg.
- Completed
- Registry status
- 272
- Enrollment target
NCT01302418 is a clinical trial that has completed, run by QIAGEN Gaithersburg. The registered enrollment target is 272 participants.
The verdict
NCT01302418 has completed, sponsored by QIAGEN Gaithersburg.
- COMPLETED
- Registry status
- 272 participants
- Enrollment target
Study Summary
The study will be conducted using nasopharyngeal swab specimens collected prospectively from individuals suspected of having the signs and symptoms of an acute respiratory tract infection caused by a respiratory virus. A series of standard viral culture tests validated for routine use in the clinical laboratory, and/or a series of PCR-based Laboratory Developed Tests (PCR-LDT) validated by a central reference laboratory will be used to verify the performance of the investigational artus Influenza A/B RT-PCR test and the QIAGEN ResPlex II Advanced Panel test. From each specimen five (5) aliquots will be prepared: (a) one aliquot will be tested in real-time using the assigned viral culture reference methods; (b) one aliquot will be used to extract nucleic acid in real-time for investigational testing; (c) one aliquot of the specimen will be stored at --70C for subsequent shipment to the reference laboratory for PCR-LDT testing, (d) one aliquot will be archived at -70C for subsequent follow-up by the reference laboratory (e.g., bi-directional sequencing of positive specimens), and (e) any remaining specimen will be stored for the Fresh vs. Frozen Study. The extracted nucleic acid generated from the second aliquot (i.e., "b" above) will be split and subjected to testing by both the artus Influenza A/B RT-PCR test and the ResPlex II Advanced Panel test.
Interventions
- DEVICE artus Influenza A/B RT-PCR Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01302418
The ClinicalTrials.gov registry entry for NCT01302418 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QIAGEN Gaithersburg, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which artus Influenza A/B RT-PCR Test is the first listed.
NCT01302418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01302418 about?
NCT01302418 is a clinical study titled "Collection and Testing of Respiratory Samples". The study will be conducted using nasopharyngeal swab specimens collected prospectively from individuals suspected of having the signs and symptoms of an acute respiratory tract infection caused by a respiratory virus. A series of standard viral culture tests validated for routine use in the clinica...
What is the current status of trial NCT01302418?
This trial is currently completed. The enrollment target is 272 participants. The study started on 2011-02. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01302418?
The interventions under investigation include: artus Influenza A/B RT-PCR Test (DEVICE).
Who is sponsoring clinical trial NCT01302418?
This trial is sponsored by QIAGEN Gaithersburg, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.